EP08.02-022 Investigating Partners in Crime: Osimertinib Resistance Mechanisms in Non-small Cell Lung Cancer Using Focused CRISPR Screen.

Autor: Dayanc, B. Uluata, Eris, S., Cakiroglu, E., Mazi, F.A., Coskun, O.S., Demirci, D., Karakulah, G., Senturk, S.
Zdroj: Journal of Thoracic Oncology; 2022 Supplement, Vol. 17 Issue 9, pS407-S407, 1p
Databáze: Complementary Index